Coherus Oncology, Inc. (CHRS)
1.63
-0.06
(-3.55%)
USD |
NASDAQ |
Mar 13, 16:00
1.635
0.00 (0.00%)
After-Hours: 20:00
Coherus Oncology Total Liabilities (Quarterly) : 204.76M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Johnson & Johnson | 117.67B |
| Stereotaxis, Inc. | 33.53M |
| Allogene Therapeutics, Inc. | 123.36M |
| Inovio Pharmaceuticals, Inc. | 51.59M |
| Nektar Therapeutics | 190.57M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 265.77M |
| Shareholders Equity (Quarterly) | 61.01M |
| Debt to Equity Ratio | 0.891 |
| Current Ratio | 1.472 |
| Net Debt Paydown Yield | 28.50% |